Transdermal Drug Delivery Systems in Diabetes Management: A Review

Diabetes mellitus is a long-term disease that happens when the pancreas does not make enough insulin, or when the body cannot use the insulin properly. More than 415 million people in the world have diabetes, and this number may reach 642 million by 2040. The World Health Organization (WHO) says that by 2030, diabetes will be the seventh leading cause of death. Most people with diabetes are treated with insulin injections or tablets, but these treatments are sometimes hard for patients to follow regularly. In recent years, scientists have started focusing on transdermal systems – special patches or devices that deliver medicine through the skin. These systems have many benefits compared to injections and tablets. Studies show that medicines given through the skin are better absorbed because they do not pass through the liver first. They also release the medicine slowly over time, which helps keep blood sugar levels steady and reduces the need to take medicine many times a day. This makes it easier for patients to follow their treatment and improves their overall health. In short, using skin patches for diabetes treatment is a new and promising method that can make diabetes control easier and more effective.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-09-25
DOI
https://doi.org/10.5281/zenodo.17197138
Primary Topic
Library Science and Administration
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Transdermal Drug Delivery Systems in Diabetes Management: A Review

Zenodo (CERN European Organization for Nuclear Research)
Library Science and Administration
article

Transdermal Drug Delivery Systems in Diabetes Management: A Review

article en

Abstract

Diabetes mellitus is a long-term disease that happens when the pancreas does not make enough insulin, or when the body cannot use the insulin properly. More than 415 million people in the world have diabetes, and this number may reach 642 million by 2040. The World Health Organization (WHO) says that by 2030, diabetes will be the seventh leading cause of death. Most people with diabetes are treated with insulin injections or tablets, but these treatments are sometimes hard for patients to follow regularly. In recent years, scientists have started focusing on transdermal systems – special patches or devices that deliver medicine through the skin. These systems have many benefits compared to injections and tablets. Studies show that medicines given through the skin are better absorbed because they do not pass through the liver first. They also release the medicine slowly over time, which helps keep blood sugar levels steady and reduces the need to take medicine many times a day. This makes it easier for patients to follow their treatment and improves their overall health. In short, using skin patches for diabetes treatment is a new and promising method that can make diabetes control easier and more effective.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 52%
Library Science and Administration
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Transdermal Drug Delivery Systems in Diabetes Management: A Review · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS